|
⚲
|
| Keyboard |
| Zaremba Rabourn Amy
✚
|
|
|---|---|
| CIK # | 0001832343 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001832343] | |
| 4 | [0001832343] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Rexahn Pharmaceuticals Inc | |
| Zaremba Rabourn Amy |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Rexahn Pharmaceuticals Inc IRD
Common Stock
|
2026-03-16 | Sell | 2,816 | $5.25 | 14,784 |
|
Rexahn Pharmaceuticals Inc IRD
Common Stock
|
2026-01-22 | Grant | 86,500 | $0.00 | |
|
Rexahn Pharmaceuticals Inc IRD
Common Stock
|
2026-01-18 | Tax withheld | 3,390 | $2.10 | 7,119 |
|
Rexahn Pharmaceuticals Inc IRD
Common Stock
|
2026-01-10 | Tax withheld | 3,950 | $1.93 | 7,624 |
|
Rexahn Pharmaceuticals Inc IRD
Employee Stock Option (right to buy) · derivative
|
2025-03-13 | Grant | 39,500 | $0.00 | |
|
Rexahn Pharmaceuticals Inc IRD
Common Stock
|
2025-03-13 | Grant | 39,500 | $0.00 | |
|
Rexahn Pharmaceuticals Inc IRD
Common Stock
|
2025-02-04 | Tax withheld | 8,190 | $1.14 | 9,337 |
|
Rexahn Pharmaceuticals Inc OCUP
Employee Stock Option (right to buy) · derivative
|
2024-01-18 | Grant | 60,000 | $0.00 | |
|
Rexahn Pharmaceuticals Inc OCUP
Common Stock
|
2024-01-18 | Grant | 40,000 | $0.00 | |
|
Rexahn Pharmaceuticals Inc OCUP
Common Stock
|
2024-01-10 | Tax withheld | 3,950 | $3.27 | 12,916 |
|
Rexahn Pharmaceuticals Inc OCUP
Common Stock
|
2023-01-10 | Grant | 46,608 | $0.00 | |
|
Rexahn Pharmaceuticals Inc OCUP
Employee Stock Option (right to buy) · derivative
|
2023-01-10 | Grant | 69,912 | $0.00 | |
|
Rexahn Pharmaceuticals Inc OCUP
Employee Stock Option (right to buy) · derivative
|
2022-01-28 | Grant | 50,000 | $0.00 | |
|
Rexahn Pharmaceuticals Inc OCUP
Employee Stock Option (right to buy) · derivative
|
2020-11-11 | Grant | 75,000 | $0.00 |